BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37799121)

  • 1. Oncologic outcomes after MRI-assisted image-guided brachytherapy with hybrid interstitial and intra-cavitary applicators under moderate sedation for locally advanced cervix cancer.
    Sommat K; Yap SP; Yeo RMC; Tan HSK; Soong YL; Tuan JKL; Sin IH
    J Contemp Brachytherapy; 2023 Aug; 15(4):245-252. PubMed ID: 37799121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical needle selection for Vienna-style applicators: improving therapeutic ratio in hybrid intracavitary-interstitial brachytherapy.
    Martin DA; Taunk NK; Anamalayil S; Mangal V; Marcel J; Hubley E
    J Contemp Brachytherapy; 2021 Oct; 13(5):533-540. PubMed ID: 34759978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-rectal ultrasound-guided hybrid intra-cavitary and interstitial brachytherapy in carcinoma cervix: A feasibility study from a tertiary cancer center in India.
    Bajwa HK; Singareddy R; Talluri AK; Kauser H; Boja DR; Srikanth G; Raju AK; Sresty NM; Mytri V
    J Contemp Brachytherapy; 2023 Jun; 15(3):198-205. PubMed ID: 37425200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance image-based 3D volume interstitial brachytherapy using polyether ether ketone catheters in advanced cervical cancer - a feasibility study.
    Palled SR; Tanvirpasha CAR; Naveen T; Sathiyan S; Kadirampatti G; Lokesh V
    J Contemp Brachytherapy; 2019 Aug; 11(4):307-311. PubMed ID: 31523230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
    Otani Y; Ohno T; Ando K; Murata K; Kato S; Noda SE; Murofushi K; Ushijima H; Yoshida D; Okonogi N; Isohashi F; Wakatsuki M; Nakano T
    J Radiat Res; 2021 May; 62(3):502-510. PubMed ID: 33532828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of single application multi-fractionated CT-guided interstitial high-dose-rate brachytherapy for locally advanced cervical cancer: A multi-institution initial experience.
    Yap ET; Dumago MP; Jainar CJ; Bojador M; Cabrera SM; Gonzalez GS; Mariano JZ; Bautista A; Mababangloob J; Genson JM; Ortin TS; Bacorro WR
    J Contemp Brachytherapy; 2023 Dec; 15(6):399-404. PubMed ID: 38230398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.
    Basu S; Manir KS; Basu A; Ghosh K
    J Contemp Brachytherapy; 2016 Oct; 8(5):399-403. PubMed ID: 27895681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
    Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
    Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
    Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
    Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Computed Tomography-Guided Image-Based Interstitial Brachytherapy for Cancer of the Cervix Using GEC-ESTRO Guidelines.
    Rishi KS; Alva RC; Kadam AR; Sharma S
    Indian J Surg Oncol; 2018 Jun; 9(2):181-186. PubMed ID: 29887698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of hybrid interstitial tandem and ring applicators for organ at risk dose reduction in small volume cervical cancer.
    Crossley N; Tipton C; Meier T; Sudhoff M; Kharofa J
    J Contemp Brachytherapy; 2020 Feb; 12(1):12-16. PubMed ID: 32190065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
    Front Oncol; 2022; 12():841980. PubMed ID: 35372065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes.
    Rivera A; Wassel M; Brodin PN; Yaparpalvi R; Velten C; Kabarriti R; Garg M; Kalnicki S; Mehta KJ
    J Contemp Brachytherapy; 2021 Apr; 13(2):158-166. PubMed ID: 33897789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of ViewRay MRI guidance for high-dose-rate brachytherapy in the treatment of cervical cancer.
    Ko HC; Huang JY; Miller JR; Das RK; Wallace CR; De Costa AA; Francis DM; Straub MR; Anderson BM; Bradley KA
    Brachytherapy; 2018; 17(4):680-688. PubMed ID: 29773331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-anesthetist-administered moderate sedation with midazolam and fentanyl for outpatient MRI-aided hybrid intracavitary and interstitial brachytherapy in cervix cancer: a single-institution experience.
    Sommat K; Lin JYX; Chew MML; Loh CS; Liew JSK; Foo YW; Kwek JW; Hennedige T; Goh JPS; Tan TK
    J Contemp Brachytherapy; 2021 Jun; 13(3):286-293. PubMed ID: 34122568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
    Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
    BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.